AJP - Regu Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 283: R663-R668, 2002. First published June 6, 2002; doi:10.1152/ajpregu.00116.2002
0363-6119/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/3/R663    most recent
00116.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braverman, A. S.
Right arrow Articles by Ruggieri, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braverman, A. S.
Right arrow Articles by Ruggieri, M. R., Sr.
Vol. 283, Issue 3, R663-R668, September 2002

Interaction between muscarinic receptor subtype signal transduction pathways mediating bladder contraction

Alan S. Braverman1, Ronald J. Tallarida2, and Michael R. Ruggieri Sr.1,2

Departments of 1 Urology and 2 Pharmacology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140

M3 muscarinic receptors mediate cholinergic-induced contraction in most smooth muscles. However, in the denervated rat bladder, M2 receptors participate in contraction because M3-selective antagonists [para-fluoro-hexahydro-sila-diphenidol (p-F-HHSiD) and 4-DAMP] have low affinities. However, the affinity of the M2-selective antagonist methoctramine in the denervated bladder is consistent with M3 receptor mediating contraction. It is possible that two pathways interact to mediate contraction: one mediated by the M2 receptor and one by the M3 receptor. To determine whether an interaction exists, the inhibitory potencies of combinations of methoctramine and p-F-HHSiD for reversing cholinergic contractions were measured. In normal bladders, all combinations gave additive effects. In denervated bladders, synergistic effects were seen with the 10:1 and 1:1 (methoctramine:p-F-HHSiD wt/wt) combinations. After application of the sarcoplasmic reticulum ATPase inhibitor thapsigargin to normal tissue, the 10:1 and 1:1 ratios became synergistic, mimicking denervated tissue. Thus in normal bladders both M2 and M3 receptors can induce contraction. In the denervated bladder, the M2 and the M3 receptors interact in a facilitatory manner to mediate contraction.

urinary bladder; synergy; denervation; second messengers


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
A. S. Braverman, R. J. Tallarida, and M. R. Ruggieri Sr.
The Use of Occupation Isoboles for Analysis of a Response Mediated by Two Receptors: M2 and M3 Muscarinic Receptor Subtype-Induced Mouse Stomach Contractions
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 954 - 960.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
K.-E. Andersson and A. J. Wein
Pharmacology of the Lower Urinary Tract: Basis for Current and Future Treatments of Urinary Incontinence
Pharmacol. Rev., December 1, 2004; 56(4): 581 - 631.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. A. Pontari, A. S. Braverman, and M. R. Ruggieri Sr.
The M2 muscarinic receptor mediates in vitro bladder contractions from patients with neurogenic bladder dysfunction
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2004; 286(5): R874 - R880.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. S. Braverman and M. R. Ruggieri Sr.
Hypertrophy changes the muscarinic receptor subtype mediating bladder contraction from M3 toward M2
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R701 - R708.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online